CB Insights released a list of what it deems to be the 50 most promising digital health companies of 2023. The market research firm said that the startups on the list are working to improve four main aspects of healthcare: personalization, efficiency, equity and accessibility.
Integral raked in $6.9 million in seed funding in this week. The San Francisco-based startup is developing technology that seeks to speed up the process of exchanging sensitive health data while still maintaining robust privacy protection.
As the value-based care market gets more crowded, startups in this space will have to nail down the fundamentals in order to attract capital from investors, healthcare business expert Paul Campbell said during a virtual conference. He encouraged startups to be crystal clear about what their value proposition is for three main stakeholders — patients, providers and payers.
Having spent a couple of decades operating within the life science industry in Colorado, the term "outlier" strikes me as quite descriptive of the experience in lesser-known biotechnology clusters.
A new group of investors is backing big data startup Lumiata‘s analytics platform that combines “the brilliance of physicians with the analytical power of big data” to make care more proactive, informed and efficient. BlueCross BlueShield Venture Partners, Sandbox Industries and AmeriHealth Inc. have funneled $6 million into the company, Lumiata said today, joining Khosla […]
Two private equity firms announced the formation of a $26.6 million fund that will focus exclusively on the aging marketplace and companies within it. Chicago-based Ziegler and Ohio-based Link-age Ventures announced the close of the Longevity Fund, which aims to address a number of key issues affecting seniors. Among them: coordination of care, chronic disease […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Cidara Therapeutics has emerged from relative obscurity with a new name, a new antifungal drug platform and a $32 million Series A financing round to help bring it to clinical trial over the next 18 months. The financing will help Cidara advance candidates from its Cloudbreak targeted immunotherapy platform, and bring its novel antifungal drug […]
A $1 million seed fund is being launched at the University of Wisconsin, with an initial aim of nudging its Alzheimer’s disease research a little closer to the bedside. Half the seed funding comes from donations to the Wisconsin Technology Innovation Institute (Wi2), a UW-affiliated nonprofit; this is matched by a $500,000 contribution from the […]
Tech startup accelerator Bizdom is putting an emphasis on health and wellness for its next session and is on the lookout for a few exciting digital health companies in (or willing to relocate to) Cleveland. Bizdom invests up to $125,000 in each startup chosen for the program and provides mentoring in sales, marketing and technology. […]
A Children’s Hospital of Philadelphia spinout with the potential to be the first to win U.S. FDA approval of a gene therapy is now funded through the rest of development of its lead treatment for inherited blindness. Spark Therapeutics is in the middle of a Phase 3 clinical trial that will determine whether the gene therapy […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Healthcare data analytics company Aver Informatics thinks the next generation of healthcare reimbursement lies in bundled payments, and now Drive Capital and GE Ventures have backed up that hypothesis too. The investors led an $8.5 million Series A that will allow the startup to expand its engineering and sales teams and accelerate growth, execs said. […]
A San Diego biotech startup focused on treating metabolic and endocrine disorders has picked up a portfolio of drug candidates and a $2.5 million investment from Ligand Pharmaceuticals (NASDAQ:LGND). Viking Therapeutics said it’s licensed five programs from Ligand, including a Phase 2 program aimed at type 2 diabetes and another at wasting syndrome in cancer. […]
Filament Labs, one of a handful of digital health startups leveraging smartphones to connect patients and their doctors during the last mile of care, will be able to build onto its flagship product thanks to a $1 million seed round. The Austin, Texas-based company markets a digital care plan delivery platform called Patient IO. Physicians […]
A young Boston company thinks it has what could be a safe, effective and noninvasive way to help overweight and obese people drop those dangerous extra pounds. Investors including PureTech Ventures and a group of prominent senior leaders from the pharmaceutical, biotech and finance sectors have just entrusted Gelesis with $12 million to continue developing […]
Now that the $1,000 genome has arrived, the healthcare industry has wasted no time putting the mass amount of genomic data being generated to work. Hospitals and companies are building analysis tools that compare an individual’s DNA data against other people’s to guide diagnosis and treatment. One challenge in doing that, according to SolveBio, is […]
